What the Word "Adaptogen" Means
Adaptogen is a category name for substances, almost always plant or fungal extracts, that are claimed to help the body resist physical, chemical, and biological stress without acting like a specific stimulant or sedative. It describes a proposed mechanism, not a chemical family, so the herbs grouped under it vary widely in composition.
The word combines the Latin adaptare, meaning to adjust or fit, with the Greek suffix -gen, meaning produced by. It was coined to describe a hoped-for class of substances that could raise the body's general resistance to stress rather than treat one specific illness or symptom.
The Term's Origin With a Soviet Pharmacologist
The word adaptogen was coined in 1947 by Soviet pharmacologist Nikolai Lazarev, who was studying dibazol, a blood-vessel-widening drug developed in France, and noticed it seemed to raise animals' resistance to a range of unrelated stresses. He proposed the term to describe this kind of general, non-specific effect.
Lazarev's original idea was later expanded by his student Israel Brekhman during the 1960s, who tested the concept on plants such as Eleutherococcus senticosus, commonly called Siberian ginseng. Brekhman is generally credited with turning adaptogen from a pharmacology footnote into a defined research category.
Brekhman's Three Defining Criteria
Brekhman proposed that a true adaptogen must meet three conditions: it should be essentially non-toxic at normal doses, it should produce a nonspecific response that increases resistance to a broad range of stressors rather than treating one problem, and it should help the body return to a normal, balanced state.
These criteria were meant to distinguish adaptogens from ordinary stimulants or drugs, which typically target one specific pathway or symptom. In practice, few substances have been rigorously tested against all three conditions in controlled human trials, so the category remains more theoretical than strictly defined.
"Nonspecific Resistance" Is an Unusual Scientific Claim
The core idea behind adaptogens, that one substance could raise resistance to many unrelated stressors at once, from cold and infection to anxiety and physical exertion, is scientifically unusual. Most pharmacology works by targeting a specific receptor or pathway tied to one narrow effect.
This is a major reason mainstream pharmacology has been slow to embrace the adaptogen framework. Proposed mechanisms involving the body's stress-response systems exist, but a single agent producing broad, nonspecific protection remains harder to prove than a drug with one clear target.
Ashwagandha: A Traditional Ayurvedic Root
Ashwagandha, or Withania somnifera, is a small shrub whose root has been used for centuries in Ayurvedic medicine in the Indian subcontinent, traditionally to support vitality and counter fatigue. It is now the most commercially popular adaptogen sold worldwide as a stress and sleep supplement.
Ashwagandha contains compounds called withanolides, which researchers believe interact with stress hormone pathways. Its long traditional use does not by itself prove modern health claims, but it has made ashwagandha one of the more heavily studied herbs in this category.
What Ashwagandha Research Shows on Cortisol
Several randomized controlled trials and recent meta-analyses have found that ashwagandha supplementation, typically 300 to 600 milligrams daily for four to twelve weeks, is associated with measurable reductions in cortisol, a hormone released during the body's stress response, compared to placebo.
Reported cortisol reductions across studies have ranged roughly from 11% to over 30%, which is a genuinely notable finding. However, a lower cortisol reading is a biomarker change, not automatically the same thing as a person feeling less stressed in daily life.
Why Perceived Stress Results Are Less Consistent
When researchers look beyond cortisol at how stressed or anxious people actually report feeling, the picture is murkier. Some reviews find ashwagandha significantly improves self-reported stress and anxiety scores; a 2025 systematic review found significant cortisol reduction but no clear effect on perceived stress.
This gap between a biological marker and a person's subjective experience is common in nutrition and supplement research. It means the cortisol-lowering effect is reasonably well supported, while the claim that ashwagandha reliably makes people feel calmer is less settled.
Rhodiola Rosea: A Cold-Climate Traditional Remedy
Rhodiola rosea is a flowering plant native to cold mountainous regions of Europe and Asia, traditionally used in Russian and Scandinavian folk medicine to combat fatigue, cold stress, and altitude sickness. It is one of the herbs most closely tied to Brekhman's original Soviet adaptogen research.
The European Medicines Agency has recognized rhodiola's traditional use for temporary relief of stress symptoms like fatigue and exhaustion, a regulatory step that acknowledges historical use without confirming a modern clinical claim of effectiveness.
What Systematic Reviews Say About Rhodiola and Fatigue
A widely cited systematic review of rhodiola trials for physical and mental fatigue found that no two included studies measured outcomes the same way, which prevented researchers from combining results into a single statistical conclusion, even though individual trials often reported some benefit.
This inconsistency across trial design is a recurring theme in adaptogen research generally. Some individual studies on rhodiola report encouraging results for stress-related fatigue, but methodological weaknesses mean the overall evidence base is still considered preliminary rather than conclusive.
Panax Ginseng: Millennia of Traditional Use
Panax ginseng has been used in Chinese traditional medicine for thousands of years, long before the word adaptogen existed, generally to strengthen the body's resistance to stress and support recovery from illness. It is chemically distinct from the unrelated Siberian ginseng.
Modern researchers frame Panax ginseng's traditional role in explicitly adaptogenic terms, studying its compounds, called ginsenosides, for effects on the immune system, cardiovascular function, and the hormonal stress response, though much of this research remains at the laboratory and animal stage.
Siberian Ginseng and the Original Soviet Trials
Eleutherococcus senticosus, commonly marketed as Siberian ginseng despite not being a true ginseng species, was the plant Brekhman used most extensively in the original Soviet adaptogen research program, testing it on workers, athletes, and soldiers for endurance and stress resistance.
Much of that early Soviet research was published in Russian-language journals with limited peer review by international standards, which makes it harder for modern scientists to independently verify. Later Western studies have tested some of the same claims with more mixed and modest results.
Holy Basil: A Widely Used but Less-Studied Adaptogen
Holy basil, or tulsi, is a plant sacred in Hindu tradition and widely used in Ayurvedic medicine as a general tonic for stress, respiratory health, and metabolic balance. It is commonly sold as tea and in capsule form alongside better-known adaptogens.
Small human trials suggest holy basil may modestly reduce self-reported stress and improve some metabolic markers, but the number of rigorous, well-controlled studies is smaller than for ashwagandha or rhodiola, leaving its adaptogenic claims comparatively less tested.
Schisandra Berry: A Five-Flavor Traditional Herb
Schisandra chinensis, called the five-flavor fruit in Chinese medicine because its berries are said to taste sweet, sour, salty, bitter, and pungent at once, has been used traditionally to support liver function and resilience to fatigue.
Laboratory studies suggest schisandra compounds may support liver enzyme activity and offer some antioxidant effects, but human clinical trials specifically testing stress-resistance claims are limited in number and scale, so its adaptogenic reputation rests more on tradition than confirmed clinical outcomes.
Reishi and Cordyceps: Fungal Adaptogens
Reishi mushroom and cordyceps are medicinal fungi, not herbs, that have been added to the adaptogen category more recently as interest in functional mushrooms has grown. Traditional Chinese and Tibetan medicine used both for vitality, immune support, and endurance.
Early research on beta-glucan compounds in reishi and cordyceps' unusual metabolites suggests possible immune-modulating and exercise-performance effects, but most supporting studies remain preclinical or involve very small human samples, so firm conclusions about their adaptogenic benefits are premature.
The Proposed Mechanism: The HPA Axis
Most modern explanations for how adaptogens might work center on the hypothalamic-pituitary-adrenal axis, the hormonal system that governs the body's stress response and cortisol release. Researchers hypothesize that certain plant compounds modulate this axis to prevent excessive or prolonged stress hormone output.
This is a biologically plausible mechanism, and some adaptogens do show measurable effects on cortisol and related stress hormones in trials. However, having a plausible mechanism is not the same as having proven, consistent clinical benefit, and the two are often conflated in marketing.
Animal Studies Versus Human Clinical Trials
A large share of adaptogen research, especially the foundational Soviet-era work and much modern laboratory science, has been conducted on rats, mice, or isolated cells rather than people. Animal results can point toward promising mechanisms but frequently fail to translate directly into human clinical benefit.
When a supplement's marketing cites "studies show," it is worth asking whether those studies involved humans taking a realistic dose over a meaningful period, or animals given doses and conditions that do not map cleanly onto everyday human use.
Why Human Evidence Remains Genuinely Limited
Even for the most studied adaptogens like ashwagandha and rhodiola, systematic reviewers consistently note that the pool of well-designed, placebo-controlled human trials is smaller than would be needed to make strong, confident public health recommendations.
This is not the same as saying the herbs definitely do not work. It means the current evidence supports cautious optimism for specific effects, like ashwagandha's cortisol reduction, while leaving broader claims of general stress protection considerably less certain.
Small Sample Sizes Are a Recurring Weakness
Many adaptogen trials enroll fewer than 100 participants, often measuring outcomes over just four to twelve weeks. Small, short trials can detect a real effect, but they are also more prone to statistical noise and less able to rule out chance results.
Larger, longer trials are more expensive and harder to fund, particularly for supplements that cannot be patented the way pharmaceutical drugs can. This economic reality partly explains why adaptogen research has lagged behind conventional drug research in scale.
Funding Sources and Publication Bias
A meaningful portion of adaptogen research, including several ashwagandha trials, has been funded by supplement manufacturers who produce the specific proprietary extract being tested. That funding pattern does not automatically invalidate results, but it can influence which studies get conducted and published.
Studies with disappointing results are also generally less likely to be submitted or accepted for publication than studies showing a benefit, a well-documented pattern known as publication bias that can make the overall published evidence look more favorable than the true underlying picture.
Dosage and Standardization Are Inconsistent
Because adaptogens are sold as unregulated dietary supplements rather than approved drugs, the concentration of active compounds can vary significantly between brands, and even between batches of the same product, unlike pharmaceuticals with strictly enforced dosing standards.
This makes it hard to compare studies directly, since one trial's "ashwagandha extract" may contain a very different withanolide concentration than another's. It also means a consumer buying a supplement off a shelf cannot be certain it matches what was tested in research.
Adaptogens Are Not Recognized as Drugs
Regulatory agencies including the United States Food and Drug Administration do not recognize "adaptogen" as a pharmacological or clinical category. Herbs marketed this way are sold as dietary supplements, which are regulated far more loosely than medications before they reach store shelves.
Under United States law, supplement manufacturers are responsible for their own safety and quality, and the FDA generally acts only after products are already on the market, through inspections, testing, and investigation of adverse event reports rather than pre-approval.
Contamination and Quality Testing Concerns
Independent testing of herbal adaptogen supplements has repeatedly found some products contaminated with heavy metals such as lead and nickel, occasionally at levels several times above recognized safety limits, particularly in products sourced from regions with less strict agricultural oversight.
This is a supply-chain and manufacturing-quality issue rather than a flaw in the herbs themselves, but it means the practical safety of a given bottle depends heavily on the specific brand's sourcing and third-party testing, not just on the herb's inherent properties.
Drug Interactions Are a Real Safety Concern
Some adaptogens can interact with common medications. Ashwagandha, for instance, may amplify the effect of thyroid medication and sedatives, while ginseng can interact with blood thinners and diabetes drugs, altering their intended effect in ways that matter clinically.
Because these herbs are sold without a prescription, many people start taking them without ever discussing potential interactions with a doctor or pharmacist, which is one of the more concrete, well-documented risks associated with adaptogen use, regardless of the debate over their benefits.
Ashwagandha and Liver or Thyroid Effects
Case reports and some clinical safety data have linked ashwagandha use to rare instances of liver injury and to changes in thyroid hormone levels, including in people without a prior thyroid condition. These effects appear uncommon but are documented closely enough to warrant caution.
Regulatory bodies in a few countries have required warning labels or restricted ashwagandha sales partly because of these reports. People with existing liver disease, thyroid disorders, or autoimmune conditions are generally advised to consult a doctor before using it.
Who Is Generally Advised to Avoid Adaptogens
Pregnant and breastfeeding people, those with autoimmune diseases, people on thyroid or blood-thinning medication, and anyone scheduled for surgery are commonly advised to avoid or discuss adaptogens with a doctor first, since safety data in these groups is often sparse or shows specific risk.
Ashwagandha, in particular, is traditionally contraindicated in pregnancy in Ayurvedic sources themselves, and modern safety reviews echo that caution given a lack of robust human trial data confirming safety for a developing fetus.
Adaptogens Are Not Stimulants, By Definition
Unlike caffeine or other stimulants, true adaptogens are not supposed to produce an immediate jolt of energy or alertness. Proponents describe their effect as gradual and cumulative, building over days or weeks of regular use rather than kicking in within an hour.
This distinction matters for expectations. Someone taking ashwagandha or rhodiola hoping for an instant energy boost, the way they might feel from coffee, is likely to be disappointed, because any genuine effect these herbs have is framed around long-term stress physiology, not acute stimulation.
Could the Placebo Effect Explain Some Reports?
Because stress and fatigue are subjective and fluctuate naturally, and because taking a daily supplement can itself create an expectation of feeling better, some portion of the benefit people report from adaptogens is likely attributable to the placebo effect, which is well documented in supplement research generally.
This is exactly why placebo-controlled trials matter so much for evaluating these herbs. Where trials do show a statistically significant difference over placebo, such as ashwagandha's cortisol effect, that gives more confidence the benefit is not purely psychological, even if it does not rule out some placebo contribution.
How Adaptogens Differ From Prescribed Anti-Anxiety Drugs
Prescription anxiolytics and antidepressants go through mandatory large-scale clinical trials, standardized dosing, and continuous safety monitoring before and after approval. Adaptogen supplements go through none of this by law, relying instead on whatever research the manufacturer or independent scientists choose to conduct.
This does not automatically mean prescription drugs are always safer or more effective for a given person, but it does mean the evidence bar and oversight behind them are fundamentally different, a distinction easily lost when adaptogens are marketed alongside claims that sound clinical.
What a Reasonable, Evidence-Based Claim Looks Like
A fair summary of the evidence supports a modest claim: certain adaptogens, ashwagandha most notably, show consistent effects on specific biological stress markers like cortisol in short-term human trials, and some individual studies report improved subjective stress or fatigue scores.
That is meaningfully different from claiming adaptogens cure anxiety, prevent burnout, or guarantee better health, which goes beyond what the current research, taken as a whole, actually demonstrates. The gap between the modest finding and the marketed claim is where most of the hype lives.
How the Supplement Industry Markets Adaptogens
Adaptogens are frequently marketed with language borrowed from clinical research, phrases like "clinically studied" or "supports the stress response," alongside imagery of ancient wisdom, which together can make claims sound more validated than the underlying evidence actually supports.
Regulators in the United States generally require supplement marketing to avoid explicit disease claims, such as "cures anxiety," pushing companies toward vaguer structure-function language instead, phrasing that is legally permitted but can still mislead a reader about the strength of the science behind it.
What Would Change the Scientific Picture
Researchers who study adaptogens generally point to the same fixes needed to strengthen the evidence: larger sample sizes, longer trial durations beyond twelve weeks, standardized extract dosing across studies, and independent funding not tied to the supplement's manufacturer.
Until those conditions are more consistently met, the field will likely keep producing the same pattern seen today, some genuinely promising signals on specific biomarkers alongside broader claims that outrun what has actually been rigorously demonstrated in people.
The Bottom Line on Adaptogens
Adaptogens are a real, historically grounded category of herbs with a plausible biological rationale and, for a handful like ashwagandha, genuine clinical evidence of measurable effects on specific stress markers such as cortisol in short-term trials.
They are not proven cures for anxiety, chronic stress, or fatigue, the evidence base for most individual herbs remains thin and inconsistent, and quality, dosing, and drug-interaction risks are real enough to warrant a doctor's input before starting one, especially for anyone on medication or with an existing health condition.
Sources
- Wikipedia: Adaptogen β history, definition, and research status
- NIH Office of Dietary Supplements: Ashwagandha β evidence and safety for professionals
- NCBI/PMC: Systematic review and meta-analysis of ashwagandha on cortisol, stress, and anxiety
- Healthline: What Are Adaptogens? Benefits and Uses
FAQ
Who invented the term "adaptogen"?
Soviet pharmacologist Nikolai Lazarev coined the term in 1947 while studying the drug dibazol. His student Israel Brekhman later expanded the concept into a defined research category using plants like Siberian ginseng.
Does ashwagandha actually lower cortisol?
Multiple randomized trials and meta-analyses show ashwagandha supplementation is associated with measurable cortisol reduction, roughly 11% to over 30% in some studies, compared to placebo, over four to twelve weeks.
Does lower cortisol mean less perceived stress?
Not necessarily. A 2025 systematic review found ashwagandha significantly reduced cortisol but did not clearly improve self-reported perceived stress scores, showing the biomarker and the subjective experience do not always move together.
Are adaptogens approved by the FDA as drugs?
No. The FDA does not recognize "adaptogen" as a pharmacological category, and these herbs are sold as dietary supplements, which face far less regulatory scrutiny before reaching the market than prescription medications.
Which adaptogen has the strongest human research behind it?
Ashwagandha currently has the largest body of randomized controlled human trials among common adaptogens, particularly for cortisol reduction, though the total number of high-quality studies is still modest by pharmaceutical standards.
Can adaptogens interact with medications?
Yes. Ashwagandha can interact with thyroid medication and sedatives, and ginseng can interact with blood thinners and diabetes drugs. Anyone on prescription medication should check with a doctor or pharmacist before starting an adaptogen.
Is ashwagandha safe during pregnancy?
No, it is generally advised against. Traditional Ayurvedic sources themselves list ashwagandha as contraindicated in pregnancy, and modern safety reviews echo this caution due to a lack of robust safety data for a developing fetus.
Do adaptogens work like caffeine or stimulants?
No. Adaptogens are not supposed to produce an immediate energy jolt. Any genuine effect is described as gradual and cumulative over days or weeks of regular use, not the acute stimulation caffeine provides within an hour.
Have adaptogen supplements been found contaminated?
Independent testing has repeatedly found some herbal adaptogen products contaminated with heavy metals like lead and nickel, occasionally several times above safety limits, mainly reflecting sourcing and manufacturing quality rather than a flaw in the herbs themselves.
Why don't larger, longer adaptogen trials exist?
Large, multi-year clinical trials are expensive, and unpatentable natural supplements offer less financial incentive to fund them compared to patentable pharmaceutical drugs, which is a major reason the evidence base has grown slowly.
Is rhodiola proven to reduce fatigue?
Evidence is suggestive but not conclusive. A widely cited systematic review found the included trials measured fatigue so inconsistently that results could not be statistically combined, even though individual studies often reported some benefit.
Are Panax ginseng and Siberian ginseng the same plant?
No. Panax ginseng is a true ginseng species used in Chinese medicine for millennia, while Siberian ginseng, Eleutherococcus senticosus, is a chemically distinct plant that only shares the marketing name, not the botanical family.
Can taking multiple adaptogens together cause problems?
It can. Combining several herbs, such as ashwagandha with ginseng and rhodiola, has rarely been tested as a blend in controlled trials, so potential interactions between the herbs themselves are not well understood.
Should someone stop taking prescribed medication in favor of adaptogens?
No. Adaptogens have not been tested or approved as substitutes for prescribed anxiety, depression, or thyroid medications, and stopping prescribed treatment without medical guidance can be dangerous regardless of any supplement being taken instead.
What is the single most reliable finding about adaptogens so far?
The most consistently replicated finding is that ashwagandha supplementation lowers cortisol levels in short-term human trials. Broader claims about stress relief, energy, or immune benefit rest on considerably thinner and more mixed evidence.
About the Author
We reference Wikipedia and other authoritative sources to explain the background and current understanding of this topic.
Loved This Article?
Share it on WhatsApp β Share it on WhatsApp
Get more guides in your inbox β Subscribe to our newsletter for weekly surprising stories from Egypt, Saudi Arabia, Dubai, and beyond.